Cargando…
Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641160/ https://www.ncbi.nlm.nih.gov/pubmed/34856989 http://dx.doi.org/10.1186/s12935-021-02369-x |
_version_ | 1784609452076302336 |
---|---|
author | Zhang, Ao Zhong, Guanqing Wang, Luocan Cai, Rongzeng Han, Runkun Xu, Caixia Chen, Shulin Sun, Peng Chen, Hao |
author_facet | Zhang, Ao Zhong, Guanqing Wang, Luocan Cai, Rongzeng Han, Runkun Xu, Caixia Chen, Shulin Sun, Peng Chen, Hao |
author_sort | Zhang, Ao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8641160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86411602021-12-03 Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma Zhang, Ao Zhong, Guanqing Wang, Luocan Cai, Rongzeng Han, Runkun Xu, Caixia Chen, Shulin Sun, Peng Chen, Hao Cancer Cell Int Correction BioMed Central 2021-12-02 /pmc/articles/PMC8641160/ /pubmed/34856989 http://dx.doi.org/10.1186/s12935-021-02369-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Zhang, Ao Zhong, Guanqing Wang, Luocan Cai, Rongzeng Han, Runkun Xu, Caixia Chen, Shulin Sun, Peng Chen, Hao Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title | Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title_full | Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title_fullStr | Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title_full_unstemmed | Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title_short | Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma |
title_sort | correction to: dynamic serum biomarkers to predict the efficacy of pd-1 in patients with nasopharyngeal carcinoma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641160/ https://www.ncbi.nlm.nih.gov/pubmed/34856989 http://dx.doi.org/10.1186/s12935-021-02369-x |
work_keys_str_mv | AT zhangao correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT zhongguanqing correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT wangluocan correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT cairongzeng correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT hanrunkun correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT xucaixia correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT chenshulin correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT sunpeng correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma AT chenhao correctiontodynamicserumbiomarkerstopredicttheefficacyofpd1inpatientswithnasopharyngealcarcinoma |